Rtw Investments as of June 30, 2016
Portfolio Holdings for Rtw Investments
Rtw Investments holds 35 positions in its portfolio as reported in the June 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals (ALNY) | 15.8 | $46M | 833k | 55.49 | |
| Incyte Corporation (INCY) | 10.7 | $31M | 392k | 79.98 | |
| Bluebird Bio (BLUE) | 9.1 | $27M | 612k | 43.29 | |
| Achillion Pharmaceuticals | 6.5 | $19M | 2.4M | 7.80 | |
| La Jolla Pharmaceuticl Com Par | 6.4 | $19M | 1.2M | 16.00 | |
| Avexis | 6.2 | $18M | 476k | 38.02 | |
| Bristol Myers Squibb (BMY) | 5.3 | $15M | 210k | 73.55 | |
| Kite Pharma | 4.9 | $14M | 286k | 50.00 | |
| Symmetry Surgical | 4.1 | $12M | 922k | 13.13 | |
| SPDR Gold Trust (GLD) | 3.6 | $11M | 83k | 126.47 | |
| Atara Biotherapeutics | 3.6 | $11M | 466k | 22.51 | |
| Agenus | 3.4 | $9.8M | 2.4M | 4.05 | |
| BioCryst Pharmaceuticals (BCRX) | 2.2 | $6.4M | 2.2M | 2.84 | |
| iShares Barclays 20+ Yr Treas.Bond (TLT) | 2.1 | $6.3M | 45k | 138.91 | |
| Dicerna Pharmaceuticals | 2.1 | $6.1M | 2.0M | 3.00 | |
| Intercept Pharmaceuticals In | 1.9 | $5.6M | 40k | 142.68 | |
| Celldex Therapeutics | 1.9 | $5.5M | 1.3M | 4.39 | |
| Omeros Corporation (OMER) | 1.9 | $5.5M | 527k | 10.52 | |
| Viveve Med | 1.1 | $3.3M | 815k | 4.10 | |
| Barclays Bank Plc etn djubscoffe38 (JJOFF) | 1.1 | $3.2M | 144k | 22.15 | |
| Corium Intl | 1.0 | $3.0M | 853k | 3.47 | |
| Invuity | 0.7 | $2.2M | 226k | 9.53 | |
| Regenxbio Inc equity us cm (RGNX) | 0.7 | $1.9M | 243k | 8.00 | |
| Five Prime Therapeutics | 0.6 | $1.8M | 45k | 41.34 | |
| Global Blood Therapeutics In | 0.6 | $1.6M | 97k | 16.59 | |
| Masimo Corporation (MASI) | 0.5 | $1.4M | 26k | 52.51 | |
| Accelr8 Technology | 0.4 | $1.1M | 75k | 14.39 | |
| Cytrx | 0.4 | $1.0M | 466k | 2.23 | |
| Sensus Healthcare | 0.3 | $1.0M | 155k | 6.49 | |
| MannKind Corporation | 0.3 | $912k | 4.4k | 207.98 | |
| Mirati Therapeutics | 0.2 | $716k | 131k | 5.46 | |
| Allscripts Healthcare Solutions (MDRX) | 0.2 | $610k | 48k | 12.71 | |
| Biopharmx | 0.2 | $455k | 701k | 0.65 | |
| Natera (NTRA) | 0.1 | $382k | 32k | 12.05 | |
| Nivalis Therapeutics | 0.1 | $138k | 30k | 4.60 |
